Based on the outcome of the first part of the study, the standard clinical protocol at the site of the Biograph TruePoint was changed.
Using the identified risk factors and experience from the first part of the study, we developed an eye-care protocol.
In the first part of the study identical RNA samples were labeled and hybridized to identical microarrays using the same platform and protocols, in both the Amsterdam and California laboratories.
But that was just the first part of the study.
This paper covers the first part of the study.
This was the first part of the study.
For the first part of the study, these patients were statistically evaluated as an exploratory data set (Cohort 1). 1 Among the 109 patients, two were omitted from statistical analyses as protocol violators.
Study began by using protocol 1 which was modified as protocol 2 in the second part of the study.
The second part of the study was prospective, we include 70 patients extubated by applying our mechanical ventilator weaning protocol.
The second part of the study focused specifically on comparison of the phenotype generated by OVA adjuvant and adjuvant-free protocols.
For the second part of the study we induced a bronchoconstriction by a continuous metacholine infusion 16-322 μg/kg per min) during ventilation with the control gas mixture and repeated the same study protocol once again.
